Abacus Property Group (ABP) Stock Price, News & Analysis

Company Overview

Abacus Property Group (ASX:ABP), is a diversified Australian REIT with an investment portfolio concentrated in the Commercial property and Self Storage sectors. We invest capital in real estate opportunities to deliver superior long term returns and maximise securityholder value. Abacus is a strong asset backed, annuity style business model where capital is directed towards assets that provide potential for enhanced income growth and ultimately create value. Our people, market insight and repositioning capability together with strategic partnering are the key enablers of our strategy. Abacus is listed on the Australian Stock Exchange and is included in the S&P/ASX 200 Index and the FTSE EPRA NAREIT Global Real Estate Index Series. Abacus is comprised of Abacus Group Holdings Limited (the nominated parent entity), Abacus Group Projects Limited and Abacus Storage Operations Limited, Abacus Trust, Abacus Income Trust and Abacus Storage Property Trust. The shares and units in these entities are stapled together and trade as one security in ABP.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.45 million shs
• Average Volume: N/A
• Market Capitalization: A$1.05 billion
• P/E Ratio: 41.35
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ABP Stock Analysis - Frequently Asked Questions

How were Abacus Property Group's earnings last quarter?

Abacus Property Group (ASX:ABP) posted its quarterly earnings results on Thursday, August, 16th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.31 by $0.01. Abacus Property Group had a trailing twelve-month return on equity of 0.74% and a net margin of 17.33%.

What other stocks do shareholders of Abacus Property Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Abacus Property Group investors own include Allena Pharmaceuticals (ALNA), Alpine Immune Sciences (ALPN), ARAVIVE (ARAV), Athersys (ATHX), Atara Biotherapeutics (ATRA), Autolus Therapeutics (AUTL) and Brainstorm Cell Therapeutics (BCLI).

Company Calendar

• Last Earnings: 8/16/2018
• Today: 9/17/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Real Estate
• Industry: REIT - Diversified
• Sub-Industry: N/A
• Current Symbol: ASX:ABP
• CIK: N/A
• Web: www.abacusproperty.com.au
• Phone: +61-2-92538600
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A$0.33
• Trailing P/E Ratio: 41.35
• Forward P/E Ratio: N/A
• P/E Growth: 7.18
• Net Income: A$286.84 million
• Net Margins: 17.33%
• Pretax Margin: N/A
• Return on Equity: 0.74%
• Return on Assets: 1.97%

Debt

• Debt-to-Equity Ratio: 29.94
• Current Ratio: 2.63
• Quick Ratio: 1.60

Sales & Book Value

• Annual Sales: A$333.62 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 10.97
• Book Value: A$3.76 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 893,660,000
• Free Float: N/A
• Market Cap: A$1.05 billion
• Optionable: Not Optionable
• Beta: 0.91